Foot and Mouth Disease Vaccines Market Size by Vaccine Type, Animal Type, Region – Segment-Level Market Assessment, Growth Opportunity Analysis, Competitive Mapping & Forecast to 2034
Overview
Foot and Mouth Disease Vaccines Market is expected to reach US$ 5.39 Bn by 2034 from US$ 3.06 Bn in 2025, at a CAGR of 6.5% during forecast period.
Foot and Mouth Disease Vaccines Market Overview:
Cattle, pigs, goats, sheep, antelopes, deer, bison, gazelles, and camelids are among the mammals susceptible to FMD. The virus that causes this sickness is picornavirus, which belongs to the Picornaviridae family.
Foot and Mouth Disease Vaccines Market Snapshot
To know about the Research Methodology :- Request Free Sample Report
Foot and Mouth Disease Vaccines Market Dynamics:
Rising demand for animal products and growing number of animals are the major factors driving the market growth.
According to data from the United States Department of Agriculture, India has over 300 million cattle, followed by Brazil and China. According to a factsheet published by the United Nations Food and Agriculture Organization (UN-FAO), there are about one billion pigs on the planet. Due to reasons such as severe environmental changes and rapid globalisation, livestock and zoonotic diseases have increased in recent decades. Various government measures mandating safe healthcare practices for livestock and companion animals are some of the primary causes driving the veterinary vaccination business, with FMD vaccinations accounting for a considerable portion. The demand for animal products such as milk, meat, and cloth has increased, attracting significant investment into the business.
The FMD vaccine market is being driven by the high prevalence of FMD and its socio-economic impact on the international commerce of animal goods. The demand for FMD vaccines is also being fuelled by the booming meat processing industry and rising dairy product consumption. Furthermore, increased demand for high-quality, disease-free meat from animals is boosting the market growth. Furthermore, governments around the world are launching a number of public awareness campaigns to safeguard endangered wildlife species like bison and antelope against FMD.
The report has profiled sixteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.
Foot and Mouth Disease Vaccines Market Segment Analysis:
The Foot and Mouth Disease Vaccines Market is segmented on the basis of Vaccine Type and Animal Type.
Based on Vaccine Type, the Conventional Vaccines lead the global market in 2025 by accounting for the largest market share xx%. The dominance of the conventional vaccines category is being aided by the rising acceptance of oil-based vaccinations, which have a longer period of effectiveness and higher efficacy. While some traditional vaccines are successful in avoiding clinical illness, they provide protection for a shorter period of time. As a result, vaccination is required on a regular basis as a preventative strategy. The most potent strains of these vaccines are stored in regions that have successfully eradicated this illness, such as North America and Europe. These strains are kept on hand in case of an emergency in order to save diverse animal species.
Based on Animal Type, the cattle segment is expected to grow at a significant CAGR during the forecast period. The enormous population of cattle around the world, as well as cattle farming's supremacy as a primary source of revenue in many nations, are driving the rise of the livestock industry. The Food and Agriculture Organization (FAO) states that there are more than 1.4 billion cattle in the world, with India, Brazil, and China accounting for the majority of them. Due to the rising demand for better and healthier meat, there is an increasing awareness of cow illnesses and zoonosis. As a result, these variables should have a beneficial impact on the market in the next years.
Foot and Mouth Disease Vaccines Market Regional Insights:
North America is expected to dominate the global market during forecast period.
Due to the introduction of animal healthcare benefits across the region, the North American area is a big contributor to the market. The regional market is expected to grow fast as a result of the presence of improved animal healthcare programmes and increased knowledge about animal health.
Asia Pacific is anticipated to grow at a lucrative rate during forecast period.
Some of the few factors that are expected to contribute to the region's increased market share include the presence of countries with greater livestock populations and important market participants. Furthermore, the market is driven by the ongoing attempts to commercialize veterinary vaccines and enhance R&D spending. Furthermore, the market is likely to be propelled by the urgent need to reduce the disease's high prevalence over the forecast period.
The report also helps in understanding market dynamics, structure by analyzing the market segments and project the market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the market make the report investor’s guide.
Foot and Mouth Disease Vaccines Market Recent Developments:
| Date | Company | Development | Impact |
|---|---|---|---|
| 14 January 2026 | Biogénesis Bagó S.A. | The company announced a major strategic agreement to ship high-potency trivalent FMD vaccines targeting SAT 1, SAT 2, and SAT 3 strains to South Africa. | The partnership secures an initial supply of 1 million doses with an additional 5 million doses scheduled by March 2026 to aggressively mitigate outbreaks in communal herds, feedlots, and dairy farms. |
| 14 January 2026 | Diamond Light Source Ltd. | The research facility published an independent impact report detailing its successful development of a next-generation virus-like particle (VLP) vaccine against foot-and-mouth disease. | The validation demonstrates that this novel infrastructure-backed vaccine could generate over $1.3 billion in annual economic benefits while significantly bolstering global livestock resilience. |
| 01 April 2026 | South African Veterinary Council | The council officially deployed its first newly recruited cohort of registered Veterinary Technicians to the specialized national FMD serology testing team following intensive competence training. | This targeted operational expansion significantly accelerates epidemiological surveillance, post-vaccination monitoring, and diagnostic capacity to reinforce the country’s FMD containment strategy. |
| 05 May 2026 | GF-TADs (FAO/WOAH) | The joint global framework agency convened an international regulatory and manufacturing assembly focused on resolving critical FMD vaccine matching and security barriers. | The initiative established new global distribution baselines to counteract the urgent regional incursion of exotic SAT1 and SAT2 viral serotypes into previously low-immunity livestock zones. |
| 01 June 2026 | Department of Agriculture (South Africa) | The agricultural ministry formalized an updated national vaccine acquisition program to combat widespread livestock disease transmission and expand global market access. | The strategic framework safeguards rural livelihoods and protects a critical sector that generated a massive $7.3 billion agricultural trade surplus. |
Foot and Mouth Disease Vaccines Market Scope: Inquire before buying
| Foot and Mouth Disease Vaccines Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | US $ 3.06 Bn. |
| Forecast Period 2026 to 2034 CAGR: | 6.5% | Market Size in 2034: | US $ 5.39 Bn. |
| Segments Covered: | by Vaccine Type | Conventional Vaccines Emergency Vaccines |
|
| by Animal Type | Cattle Sheep and goat Pig Others |
||
Foot and Mouth Disease Vaccines Market, by Region:
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Foot and Mouth Disease Vaccines Market Key Players:
1. FMD Vaccines & Veterinary Biologics
These companies develop and manufacture vaccines used for prevention and control of Foot-and-Mouth Disease outbreaks in livestock.
Europe
1. Boehringer Ingelheim Animal Health – Germany
2. Ceva Santé Animale – France
3. Bioveta, a.s. – Czech Republic
North America
1. Zoetis Inc. – United States
2. Elanco Animal Health Incorporated – United States
Asia Pacific
1. Indian Immunologicals Limited – India
2. Biogenesis Bago S.A. (Asia Operations) – Regional Presence
3. China Animal Husbandry Industry Co., Ltd. (CAHIC) – China
2. Veterinary Diagnostics & Disease Surveillance
These companies provide diagnostic kits, laboratory testing, molecular diagnostics, and surveillance tools for FMD detection and outbreak monitoring.
Europe
1. INDICAL Bioscience GmbH – Germany
2. QIAGEN N.V. – Netherlands
North America
1. Thermo Fisher Scientific Inc. – United States
2. IDEXX Laboratories, Inc. – United States
Asia Pacific
1. Fujifilm Wako Pure Chemical Corporation – Japan
3. Animal Health & Livestock Disease Management
These companies provide broader livestock health solutions including vaccines, disease prevention programs, and herd health management.
Europe
1. Boehringer Ingelheim Animal Health – Germany
2. Ceva Santé Animale – France
North America
1. Zoetis Inc. – United States
2. Elanco Animal Health Incorporated – United States
3. Merck Animal Health – United States
Asia Pacific
1. Indian Immunologicals Limited – India
2. Hester Biosciences Limited – India
4. Veterinary Biological Research & Vaccine Innovation
These organizations and companies focus on advanced vaccine development, antigen banks, and next-generation FMD prevention technologies.
Europe
1. Boehringer Ingelheim Animal Health – Germany
2. Ceva Santé Animale – France
North America
1. Zoetis Inc. – United States
Asia Pacific
1. Indian Immunologicals Limited – India
2. China Animal Husbandry Industry Co., Ltd. (CAHIC) – China
5. Contract Manufacturing & Veterinary Vaccine Production
Companies involved in large-scale production, formulation, and supply of veterinary vaccines for government vaccination programs and livestock industries.
Europe
1. Bioveta, a.s. – Czech Republic
North America
1. Zoetis Inc. – United States
Asia Pacific
1. Indian Immunologicals Limited – India
2. Hester Biosciences Limited – India
3. CAHIC – China
Frequently Asked Questions:
1. Which region has the largest share in Foot and Mouth Disease Vaccines Market?
Ans: North America region holds the highest share in 2025.
2. What is the growth rate of Foot and Mouth Disease Vaccines Market?
Ans: The Foot and Mouth Disease Vaccines Market is growing at a CAGR of 6.5% during forecasting period 2026-2034.
3. What segments are covered in Foot and Mouth Disease Vaccines Market?
Ans: Foot and Mouth Disease Vaccines Market is segmented into vaccine type, animal type and region.
4. Who are the key players in Foot and Mouth Disease Vaccines Market?
Ans: The important key players in the Foot and Mouth Disease Vaccines Market are – India Immunological Ltd., Merck Animal Health, Brilliant Bio Pharma Ltd., Ceva Santé Animale, Boehringer Ingelheim GmbH, Biovet Private Limited,
5. What is the study period of this market?
Ans: The Foot and Mouth Disease Vaccines Market is studied from 2025 to 2034.